{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:49:01Z","timestamp":1785944941459,"version":"3.56.0"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[1998,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The surface M protein of group A streptococci (GAS) is one of the major virulence factors for this pathogen. Antibodies to the M protein can facilitate opsonophagocytosis by phagocytic cells present in human blood. We investigated whether pooled normal immunoglobulin G (IVIG) contains antibodies that can opsonize and enhance the phagocytosis of type M1 strains of GAS and whether the levels of these antibodies vary for different IVIG preparations. We focused on the presence of anti-M1 antibodies because the M1T1 serotype accounts for the majority of recent invasive GAS clinical isolates in our surveillance studies. The level of anti-M1 antibodies in three commercial IVIG preparations was determined by enzyme-linked immunosorbent assay (ELISA), and the opsonic activity of these antibodies was determined by neutrophil-mediated opsonophagocytosis of a representative M1T1 isolate. High levels of opsonic anti-M1 antibodies were found in all IVIG preparations tested, and there was a good correlation between ELISA titers and opsonophagocytic activity. However, there was no significant difference in the levels of opsonic anti-M1 antibodies among the various IVIG preparations or lots tested. Adsorption of IVIG with M1T1 bacteria removed the anti-M1 opsonic activity, while the level of anti-M3 opsonophagocytosis was unchanged. Plasma was obtained from seven patients with streptococcal toxic shock syndrome who received IVIG therapy, and the level of anti-M1 antibodies was assessed before and after IVIG administration. A significant increase in the level of type M1-specific antibodies was found in the plasma of all patients who received IVIG therapy (<jats:italic>P<\/jats:italic>&lt; 0.006). The results reveal another potential mechanism by which IVIG can ameliorate severe invasive group A streptococcal infections.<\/jats:p>","DOI":"10.1128\/iai.66.5.2279-2283.1998","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T15:25:39Z","timestamp":1577805939000},"page":"2279-2283","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":46,"title":["Opsonic Antibodies to the Surface M Protein of Group A Streptococci in Pooled Normal Immunoglobulins (IVIG): Potential Impact on the Clinical Efficacy of IVIG Therapy for Severe Invasive Group A Streptococcal Infections"],"prefix":"10.1128","volume":"66","author":[{"given":"Hesham","family":"Basma","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Research Service, Veterans Affairs Medical Center, Memphis, Tennessee 381041;"},{"name":"<!--label omitted: 2-->Departments of Surgery and of Microbiology and Immunology, University of Tennessee, Memphis, Tennessee 381632;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Norrby-Teglund","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Research Service, Veterans Affairs Medical Center, Memphis, Tennessee 381041;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"McGeer","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Microbiology, Mount Sinai Hospital, and the University of Toronto, Toronto, Ontario, Canada3; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald E.","family":"Low","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Microbiology, Mount Sinai Hospital, and the University of Toronto, Toronto, Ontario, Canada3; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"El-Ahmedy","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Research Service, Veterans Affairs Medical Center, Memphis, Tennessee 381041;"},{"name":"<!--label omitted: 2-->Departments of Surgery and of Microbiology and Immunology, University of Tennessee, Memphis, Tennessee 381632;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Dale","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Research Service, Veterans Affairs Medical Center, Memphis, Tennessee 381041;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Schwartz","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Centers for Disease Control and Prevention, Atlanta, Georgia 303334"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"Kotb","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Research Service, Veterans Affairs Medical Center, Memphis, Tennessee 381041;"},{"name":"<!--label omitted: 2-->Departments of Surgery and of Microbiology and Immunology, University of Tennessee, Memphis, Tennessee 381632;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480240077038"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(88)80027-6"},{"key":"e_1_3_2_4_2","first-page":"401","article-title":"Primary structure and immunochemistry of group A streptococcal M proteins.","volume":"4","author":"Beachey E. H.","year":"1982","unstructured":"Beachey E. H. Seyer J. M. Primary structure and immunochemistry of group A streptococcal M proteins. Semin. Infect. Dis. 4 1982 401 410","journal-title":"Semin. Infect. Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601253340407"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.11.4744-4750.1996"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90339-5"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608223350803"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/16.6.792"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199110001-00005"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00918364"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/scientificamerican0691-58"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1017\/S095026880006739X"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/16.10.4667"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/j.1875-9114.1993.tb02759.x","article-title":"Immunomodulation with intravenous immunoglobulin.","volume":"13","author":"Hall P. D.","year":"1993","unstructured":"Hall P. D. Immunomodulation with intravenous immunoglobulin. Pharmacotherapy 13 1993 564 573","journal-title":"Pharmacotherapy"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Herwald H. M. Collin W. Muller-Esterl and L. Bjorck. 1996. Streptococcal cysteine proteinase releases kinins: a virulence mechanism. J. Exp. Med. 665\u2013673.","DOI":"10.1084\/jem.184.2.665"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.1.31"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(88)96073-2"},{"key":"e_1_3_2_19_2","unstructured":"Janeway C. A. Emnders J. F. Oncley J. L. Use of fraction II-3 in the preparation of serum gammaglobulin (human). 1946Memorandum to Division of Medical Sciences National Research Council."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.16.7676"},{"key":"e_1_3_2_21_2","unstructured":"Kaul R. McGeer A. Norrby-Teglund A. Kotb M. Low D. E. Intravenous immunoglobulin (IVIG) therapy in streptococcal toxic shock syndrome (STSS): results of a matched case-control study abstr. LM68. Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1995 American Society for Microbiology Washington D.C"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","unstructured":"Kaveri S. V. L. Mouthon and M. D. Kazatchkine. 1994. Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases. J. Neurol. Neurosurg. Psychiatry 57 (Suppl.) : 6\u20138.","DOI":"10.1136\/jnnp.57.Suppl.6"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.3.411"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.4049\/jimmunol.145.12.4089","article-title":"Identification of an epitope of type 1 streptococcal M protein that is shared with a 43-kD protein of human myocardium and renal glomeruli.","volume":"145","author":"Kraus W.","year":"1990","unstructured":"Kraus W. Dale J. B. Beachey E. H. Identification of an epitope of type 1 streptococcal M protein that is shared with a 43-kD protein of human myocardium and renal glomeruli. J. Immunol. 145 1990 4089 4093","journal-title":"J. Immunol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.89.3.307","article-title":"Current knowledge of the type-specific M antigens of group A streptococci.","volume":"89","author":"Lancefield R. L.","year":"1962","unstructured":"Lancefield R. L. Current knowledge of the type-specific M antigens of group A streptococci. J. Immunol. 89 1962 307 313","journal-title":"J. Immunol."},{"key":"e_1_3_2_26_2","unstructured":"Low D. E. B. Schwartz and A. McGeer. The reemergence of severe group A streptococcal disease: an evolutionary perspective. In Emerging pathogens. Proceedings of the 1996 International Congress on Antimicrobial Agents and Chemotherapy in press."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2185544"},{"key":"e_1_3_2_28_2","unstructured":"McGeer A. et al. Unpublished data."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(11)80362-1"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.3.994-1003.1995"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(06)80014-4"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198608073150601"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/514588"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.12.5395-5398.1996"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.4049\/jimmunol.156.8.3057","article-title":"Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.","volume":"156","author":"Norrby-Teglund A.","year":"1996","unstructured":"Norrby-Teglund A. Kaul R. Low D. E. McGeer A. Newton D. W. Andersson J. Andersson U. Kotb M. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J. Immunol. 156 1996 3057 3064","journal-title":"J. Immunol."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.9.3731-3738.1994"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1995.tb02548.x"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.5.997"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240420"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549209054644"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.1.2"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-199106000-00014"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116240"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.11.4733-4738.1996"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199412000-00010"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500030088038"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.66.5.2279-2283.1998","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.66.5.2279-2283.1998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T11:52:10Z","timestamp":1722253930000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.66.5.2279-2283.1998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["10.1128\/IAI.66.5.2279-2283.1998"],"URL":"https:\/\/doi.org\/10.1128\/iai.66.5.2279-2283.1998","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]},"assertion":[{"value":"1997-10-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-02-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}